4d Molecular Therapeutics, Inc. · NASDAQ:FDMT

Goldman Sachs Group Inc reported a 9.60% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 10, 2025

Goldman Sachs Group Inc reported a 9.60% stake in 4d Molecular Therapeutics, Inc., 4,423,435 shares, as a passive investor on Dec 31, 2024. Filed Feb 10, 2025 (Schedule 13G/A).

Stake
9.60%
Shares
4,423,435
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.9.60%4,423,435
GOLDMAN SACHS & CO. LLC9.60%4,423,435

Source

View original at SEC

Related